ENVB enveric.com Aggregate Debt Obligations

Enveric Biosciences (ENVB) is developing the Psybrary AI system for the precise synthesis of anti-anxiety compounds, securing its developments through patents. The market capitalization trend on GURU.Markets, where the indicator stands at 0.00, is based on the creation of intellectual capital in neuropsychiatry and partnerships with corporate behemoths. High-intensity R&D processes regarding psilocybin molecules currently provide the company with a peak of research activity.

Enveric Biosciences, Inc. - ENVB Company Debts (period 07/04/2022 - 10/28/2026)

ENVB (Enveric Biosciences, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:

Stock Price Enveric Corp|ENVB - Price Target Chart

- market capitalization data:

Market Value Enveric|ENVB - Enterprise Value

- book capitalization data:

Accounting Value per Share Enveric Biosciences|ENVB - Company Book Value|Market-to-Book Ratio enveric.com|ENVB - Cumulative Company Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio Enveric Biosciences|ENVB - Long-Term Debt to Capital|Current Liabilities to Equity Enveric Biosciences Inc|ENVB - Company Aggregate Debts|Debts to Book Capitalization Enveric|ENVB - Company Long-Term Debt|Company Short-Term Loans and Borrowings Enveric Biosciences

General company analysis:Enveric Corp ENVB

This indicator aggregates all external financial liabilities of the issuer, allowing for an assessment of default risk and the extent to which operational activities depend on borrowed capital. Analyzing total loans and credits is critically important for Enveric Biosciences (ENVB), as a minimal debt load ensures financial stability during the development of unique Psybrary AI-driven drugs amid inelastic demand in the psychopharmacology market.

Main competitors